857: Aggravation of ER stress by combination of proteasome inhibitors and HIV protease inhibitors results in preferencial killing of triple-negative breast cancer cells in vitro.

MLA

Gibbons Marsico, J., et al. “857: Aggravation of ER Stress by Combination of Proteasome Inhibitors and HIV Protease Inhibitors Results in Preferencial Killing of Triple-Negative Breast Cancer Cells in Vitro.” European Journal of Cancer, vol. 50, July 2014, p. S209. EBSCOhost, https://doi.org/10.1016/S0959-8049(14)50760-5.

APA

Gibbons Marsico, J., Heger, T., Kraus, M., Bader, J., Jörger, M., & Driessen, C. H. (2014). 857: Aggravation of ER stress by combination of proteasome inhibitors and HIV protease inhibitors results in preferencial killing of triple-negative breast cancer cells in vitro. European Journal of Cancer, 50, S209. https://doi.org/10.1016/S0959-8049(14)50760-5

Chicago

Gibbons Marsico, J., T. Heger, M. Kraus, J. Bader, M. Jörger, and C.H. Driessen. 2014. “857: Aggravation of ER Stress by Combination of Proteasome Inhibitors and HIV Protease Inhibitors Results in Preferencial Killing of Triple-Negative Breast Cancer Cells in Vitro.” European Journal of Cancer 50 (July): S209. doi:10.1016/S0959-8049(14)50760-5.